Another study also showed that the AIM2 expression was absent in nearly two-thirds of CRC patients and the loss of the AIM2 expression may be an important biomarker to evaluate and identify CRC patients with a poor prognosis [117]. Here, AIM2 is linked to colorectal carcinoma.